ID   DMF10.62.3
AC   CVCL_A2KE
SY   DMF10-62-3
DR   ATCC; PTA-377
DR   Wikidata; Q105506766
RX   Patent=US8444972;
RX   Patent=WO2004083387A2;
RX   PubMed=10415028;
RX   PubMed=16024647;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-377.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI:60327; Ganglioside GM2.
OX   NCBI_TaxID=10032; ! Cricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
RX   Patent=US8444972;
RA   Rock K.L., Fernandes D.M.;
RT   "Antitumor antibodies, proteins, and uses thereof.";
RL   Patent number US8444972, 21-May-2013.
//
RX   Patent=WO2004083387A2;
RA   Fanger G.R.;
RT   "Anti-ganglioside antibodies and methods of use.";
RL   Patent number WO2004083387A2, 30-Oct-2004.
//
RX   PubMed=10415028; DOI=10.4049/jimmunol.163.3.1306;
RA   Fernandes D.M., Baird A.M., Berg L.J., Rock K.L.;
RT   "A monoclonal antibody reactive with a 40-kDa molecule on fetal
RT   thymocytes and tumor cells blocks proliferation and stimulates
RT   aggregation and apoptosis.";
RL   J. Immunol. 163:1306-1314(1999).
//
RX   PubMed=16024647; DOI=10.1158/0008-5472.CAN-05-0300;
RA   Retter M.W., Johnson J.C., Peckham D.W., Bannink J.E., Bangur C.S.,
RA   Dresser K., Cai F., Foy T.M., Fanger N.A., Fanger G.R., Woda B.,
RA   Rock K.L.;
RT   "Characterization of a proapoptotic antiganglioside GM2 monoclonal
RT   antibody and evaluation of its therapeutic effect on melanoma and
RT   small cell lung carcinoma xenografts.";
RL   Cancer Res. 65:6425-6434(2005).
//